这是一篇来自已证抗体库的有关人类 HLA-DRB1 (HLA-DRB1) 的综述,是根据179篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合HLA-DRB1 抗体。
HLA-DRB1 同义词: DRB1; HLA-DR1B; HLA-DRB; SS1

BioLegend
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 s1c
BioLegendHLA-DRB1抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上 (图 s1c). BMC Cancer (2020) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 3:50; 图 1c
BioLegendHLA-DRB1抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上浓度为3:50 (图 1c). Science (2020) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 1:100; 图 s20c
BioLegendHLA-DRB1抗体(Biolegend, 307642)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 s20c). Nat Commun (2020) ncbi
小鼠 单克隆(L243)
  • mass cytometry; 人类; 0.5 mg/ml; 图 s11a
BioLegendHLA-DRB1抗体(Biolegend, L243)被用于被用于mass cytometry在人类样本上浓度为0.5 mg/ml (图 s11a). Nature (2020) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 s20
BioLegendHLA-DRB1抗体(Biolegend, 307640)被用于被用于流式细胞仪在人类样本上 (图 s20). Science (2019) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 6b
BioLegendHLA-DRB1抗体(Biolegend, 307640)被用于被用于流式细胞仪在人类样本上 (图 6b). Cell Rep (2019) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 7a
BioLegendHLA-DRB1抗体(BioLegend, 307629)被用于被用于流式细胞仪在人类样本上 (图 7a). J Exp Med (2020) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 s6c
BioLegendHLA-DRB1抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上 (图 s6c). Science (2019) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 1:50; 图 e4f
BioLegendHLA-DRB1抗体(Biolegend, 307619)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 e4f). Nature (2019) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
BioLegendHLA-DRB1抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上. JCI Insight (2019) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 2d
BioLegendHLA-DRB1抗体(Biolegend, 307642)被用于被用于流式细胞仪在人类样本上 (图 2d). Immunity (2019) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 s2d
BioLegendHLA-DRB1抗体(Biolegend, 307602)被用于被用于流式细胞仪在人类样本上 (图 s2d). Cell (2019) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 8a
BioLegendHLA-DRB1抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上 (图 8a). elife (2019) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 1b
BioLegendHLA-DRB1抗体(Biolegend, 307626)被用于被用于流式细胞仪在人类样本上 (图 1b). Cell Mol Gastroenterol Hepatol (2020) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 6
BioLegendHLA-DRB1抗体(BioLegend, 307603)被用于被用于流式细胞仪在人类样本上 (图 6). Gastroenterol Res Pract (2019) ncbi
小鼠 单克隆(Tu39)
  • 抑制或激活实验; 人类; 20 ug/ml; 图 s3i
BioLegendHLA-DRB1抗体(Biolegend, 361702)被用于被用于抑制或激活实验在人类样本上浓度为20 ug/ml (图 s3i). Cancer Cell (2019) ncbi
小鼠 单克隆(L243)
  • 其他; 人类; 图 4b
BioLegendHLA-DRB1抗体(BioLegend, 307659)被用于被用于其他在人类样本上 (图 4b). Cell (2019) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 s1
BioLegendHLA-DRB1抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上 (图 s1). JCI Insight (2019) ncbi
小鼠 单克隆(L243)
  • mass cytometry; 人类; 图 s1
BioLegendHLA-DRB1抗体(BioLegend, L243)被用于被用于mass cytometry在人类样本上 (图 s1). J Exp Med (2019) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 s1b
BioLegendHLA-DRB1抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上 (图 s1b). J Clin Invest (2019) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 1a
BioLegendHLA-DRB1抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上 (图 1a). BMC Res Notes (2019) ncbi
小鼠 单克隆(L243)
  • mass cytometry; 人类; 图 2b
BioLegendHLA-DRB1抗体(Biolegend, 307602)被用于被用于mass cytometry在人类样本上 (图 2b). Cell (2019) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 1:100; 图 s1c, s3a
BioLegendHLA-DRB1抗体(Biolegend, 307650)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 s1c, s3a). Cancer Cell (2019) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 2 ug/ml; 图 s13
BioLegendHLA-DRB1抗体(BioLegend, 307623)被用于被用于流式细胞仪在人类样本上浓度为2 ug/ml (图 s13). Science (2019) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类; 图 3g
BioLegendHLA-DRB1抗体(Biolegend, 327014)被用于被用于流式细胞仪在人类样本上 (图 3g). Science (2019) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 3a
BioLegendHLA-DRB1抗体(BioLegend, 307624)被用于被用于流式细胞仪在人类样本上 (图 3a). J Clin Invest (2019) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 1:1; 图 5a
BioLegendHLA-DRB1抗体(BioLegend, 307610)被用于被用于流式细胞仪在人类样本上浓度为1:1 (图 5a). Nat Commun (2019) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类; 图 1a
BioLegendHLA-DRB1抗体(Biolegend, LN3)被用于被用于流式细胞仪在人类样本上 (图 1a). Front Immunol (2018) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 1a
BioLegendHLA-DRB1抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上 (图 1a). Front Immunol (2018) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 1:200; 图 1b
BioLegendHLA-DRB1抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 1b). Front Immunol (2018) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 s3k
BioLegendHLA-DRB1抗体(Biolegend, 307618)被用于被用于流式细胞仪在人类样本上 (图 s3k). Cell Rep (2018) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 小鼠; 图 3b
BioLegendHLA-DRB1抗体(BioLegend, L243)被用于被用于流式细胞仪在小鼠样本上 (图 3b). J Clin Invest (2019) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 4a
BioLegendHLA-DRB1抗体(BioLegend, 307618)被用于被用于流式细胞仪在人类样本上 (图 4a). J Exp Med (2018) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 s1c
BioLegendHLA-DRB1抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上 (图 s1c). J Immunol (2018) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 1a
BioLegendHLA-DRB1抗体(Biolegend, 307602)被用于被用于流式细胞仪在人类样本上 (图 1a). Cell (2018) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 s2d
BioLegendHLA-DRB1抗体(BioLegend, 307624)被用于被用于流式细胞仪在人类样本上 (图 s2d). Nat Immunol (2018) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 1a
BioLegendHLA-DRB1抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上 (图 1a). J Immunol (2018) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 s3b
BioLegendHLA-DRB1抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上 (图 s3b). J Exp Med (2018) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 1a
BioLegendHLA-DRB1抗体(Biolegend, 307616)被用于被用于流式细胞仪在人类样本上 (图 1a). J Clin Invest (2018) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 1a
BioLegendHLA-DRB1抗体(Biolegend, 307616)被用于被用于流式细胞仪在人类样本上 (图 1a). Nucleic Acids Res (2018) ncbi
小鼠 单克隆(L243)
  • 抑制或激活实验; 人类; 图 s2b
BioLegendHLA-DRB1抗体(BioLegend, L243)被用于被用于抑制或激活实验在人类样本上 (图 s2b). Nat Med (2018) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 s1
BioLegendHLA-DRB1抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上 (图 s1). J Biol Chem (2018) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 4a
BioLegendHLA-DRB1抗体(BioLegend, H243)被用于被用于流式细胞仪在人类样本上 (图 4a). Int J Infect Dis (2018) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 1b
BioLegendHLA-DRB1抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上 (图 1b). JCI Insight (2018) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 3b
BioLegendHLA-DRB1抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上 (图 3b). Oncol Lett (2018) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 1a
BioLegendHLA-DRB1抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上 (图 1a). J Exp Med (2018) ncbi
小鼠 单克隆(L243)
  • mass cytometry; 人类; 图 2a
BioLegendHLA-DRB1抗体(BioLegend, L243)被用于被用于mass cytometry在人类样本上 (图 2a). Proc Natl Acad Sci U S A (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 1:50
BioLegendHLA-DRB1抗体(BioLegend, 307616)被用于被用于流式细胞仪在人类样本上浓度为1:50. Science (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 表 s3
BioLegendHLA-DRB1抗体(biolegend, L243)被用于被用于流式细胞仪在人类样本上 (表 s3). Cell (2017) ncbi
小鼠 单克隆(L243)
  • mass cytometry; 人类; 图 1h
  • 流式细胞仪; 人类
BioLegendHLA-DRB1抗体(Biolegend, L243)被用于被用于mass cytometry在人类样本上 (图 1h) 和 被用于流式细胞仪在人类样本上. Science (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 s6a
BioLegendHLA-DRB1抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上 (图 s6a). MBio (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 st12
BioLegendHLA-DRB1抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上 (图 st12). Science (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 2e
BioLegendHLA-DRB1抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上 (图 2e). Oncoimmunology (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 1:200; 图 s1d
BioLegendHLA-DRB1抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 s1d). Nat Commun (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 2b
BioLegendHLA-DRB1抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上 (图 2b). Genome Med (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 小鼠; 图 2d
BioLegendHLA-DRB1抗体(BioLegend, L243)被用于被用于流式细胞仪在小鼠样本上 (图 2d). J Clin Invest (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 猕猴; 图 7a
BioLegendHLA-DRB1抗体(Biolegend, L243)被用于被用于流式细胞仪在猕猴样本上 (图 7a). J Virol (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 表 1
BioLegendHLA-DRB1抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上 (表 1). Cytometry A (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 3b
BioLegendHLA-DRB1抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上 (图 3b). Oncotarget (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
BioLegendHLA-DRB1抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上. J Exp Med (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 2a
BioLegendHLA-DRB1抗体(BioLegend, 307606)被用于被用于流式细胞仪在人类样本上 (图 2a). Oncogene (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 小鼠; 图 1c
BioLegendHLA-DRB1抗体(BioLegend, L243)被用于被用于流式细胞仪在小鼠样本上 (图 1c). J Immunol (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 表 2
BioLegendHLA-DRB1抗体(Biolegend, 307624)被用于被用于流式细胞仪在人类样本上 (表 2). J Allergy Clin Immunol (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 2b
BioLegendHLA-DRB1抗体(Biolegend, 307628)被用于被用于流式细胞仪在人类样本上 (图 2b). Cell Death Dis (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
BioLegendHLA-DRB1抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上. J Allergy Clin Immunol (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 1b
BioLegendHLA-DRB1抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上 (图 1b). Eur J Immunol (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 6a
BioLegendHLA-DRB1抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上 (图 6a). J Biol Chem (2016) ncbi
小鼠 单克隆(LN3)
  • 免疫细胞化学; 人类; 0.5 ug/ml; 图 1
BioLegendHLA-DRB1抗体(Biolegend, 327002)被用于被用于免疫细胞化学在人类样本上浓度为0.5 ug/ml (图 1). Microbes Infect (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 2b
BioLegendHLA-DRB1抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上 (图 2b). PLoS ONE (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 7a
BioLegendHLA-DRB1抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上 (图 7a). J Biol Chem (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 s3
BioLegendHLA-DRB1抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上 (图 s3). Nature (2016) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类; 表 1
BioLegendHLA-DRB1抗体(BioLegend, LN3)被用于被用于流式细胞仪在人类样本上 (表 1). J Immunol (2016) ncbi
小鼠 单克隆(Tu39)
  • 流式细胞仪; 人类; 表 1
BioLegendHLA-DRB1抗体(BioLegend, Tu39)被用于被用于流式细胞仪在人类样本上 (表 1). J Immunol (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 3
BioLegendHLA-DRB1抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上 (图 3). Am J Transplant (2016) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类; 1:400; 图 2
BioLegendHLA-DRB1抗体(Biolegend, LN3)被用于被用于流式细胞仪在人类样本上浓度为1:400 (图 2). PLoS ONE (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 s1c
  • 免疫细胞化学; 人类
BioLegendHLA-DRB1抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上 (图 s1c) 和 被用于免疫细胞化学在人类样本上. J Allergy Clin Immunol (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 1:200; 图 s1a
BioLegendHLA-DRB1抗体(Biolegend, 307616)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 s1a). Acta Neuropathol (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 s6a
BioLegendHLA-DRB1抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上 (图 s6a). Oncotarget (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 1:20; 图 2
BioLegendHLA-DRB1抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上浓度为1:20 (图 2). Nat Commun (2016) ncbi
小鼠 单克隆(L243)
  • 其他; 人类; 图 st1
  • 流式细胞仪; 人类; 图 st3
BioLegendHLA-DRB1抗体(BioLegend, L243)被用于被用于其他在人类样本上 (图 st1) 和 被用于流式细胞仪在人类样本上 (图 st3). Mol Cell Proteomics (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 1a
BioLegendHLA-DRB1抗体(BioLegend, 307610)被用于被用于流式细胞仪在人类样本上 (图 1a). J Immunol (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 s1b
BioLegendHLA-DRB1抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上 (图 s1b). J Immunol (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 1
BioLegendHLA-DRB1抗体(Biolegend, 307628)被用于被用于流式细胞仪在人类样本上 (图 1). PLoS ONE (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
BioLegendHLA-DRB1抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上. Clin Cancer Res (2016) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类; 图 1
BioLegendHLA-DRB1抗体(Biolegend, clone LN3)被用于被用于流式细胞仪在人类样本上 (图 1). PLoS ONE (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
BioLegendHLA-DRB1抗体(Biolegend, 307604)被用于被用于流式细胞仪在人类样本上. Cytometry A (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 2a
BioLegendHLA-DRB1抗体(Biolegend, 307602)被用于被用于流式细胞仪在人类样本上 (图 2a). Mol Med Rep (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 表 1
BioLegendHLA-DRB1抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上 (表 1). Cytometry B Clin Cytom (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 3
BioLegendHLA-DRB1抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上 (图 3). Mucosal Immunol (2016) ncbi
小鼠 单克隆(Tu39)
  • 流式细胞仪; 人类
BioLegendHLA-DRB1抗体(Biolegend, #361703)被用于被用于流式细胞仪在人类样本上. Am J Transplant (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 表 s1
BioLegendHLA-DRB1抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上 (表 s1). PLoS ONE (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 9a
BioLegendHLA-DRB1抗体(Biolegend, 307617)被用于被用于流式细胞仪在人类样本上 (图 9a). EMBO Mol Med (2015) ncbi
小鼠 单克隆(L243)
  • 抑制或激活实验; 人类; 15 ug/ml; 图 4
BioLegendHLA-DRB1抗体(BioLegend, L432)被用于被用于抑制或激活实验在人类样本上浓度为15 ug/ml (图 4). Vaccine (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
BioLegendHLA-DRB1抗体(BioLegend, clone L243)被用于被用于流式细胞仪在人类样本上. Chest (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 5
BioLegendHLA-DRB1抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上 (图 5). Clin Cancer Res (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 3
BioLegendHLA-DRB1抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上 (图 3). Nephrol Dial Transplant (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
BioLegendHLA-DRB1抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上. Eur J Immunol (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
BioLegendHLA-DRB1抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
BioLegendHLA-DRB1抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上. J Leukoc Biol (2014) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 1
BioLegendHLA-DRB1抗体(Biolegend, 307604)被用于被用于流式细胞仪在人类样本上 (图 1). PLoS Pathog (2014) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
BioLegendHLA-DRB1抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上. Blood (2014) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
BioLegendHLA-DRB1抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上. Front Immunol (2014) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 6b
BioLegendHLA-DRB1抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上 (图 6b). J Immunol (2014) ncbi
小鼠 单克隆(L243)
BioLegendHLA-DRB1抗体(Biolegend, L243)被用于. J Immunol (2014) ncbi
小鼠 单克隆(L243)
  • 抑制或激活实验; 人类; 图 5A
BioLegendHLA-DRB1抗体(BioLegend, L243)被用于被用于抑制或激活实验在人类样本上 (图 5A). J Immunol (2014) ncbi
赛默飞世尔
小鼠 单克隆(TU36)
  • mass cytometry; 人类; 图 2b, 2s8a
赛默飞世尔HLA-DRB1抗体(Invitrogen, Tu36)被用于被用于mass cytometry在人类样本上 (图 2b, 2s8a). elife (2020) ncbi
小鼠 单克隆(LN-3)
  • 免疫组化; 小鼠; 图 1
赛默飞世尔HLA-DRB1抗体(eBioscience, LN3)被用于被用于免疫组化在小鼠样本上 (图 1). JCI Insight (2019) ncbi
小鼠 单克隆(LN3)
  • 免疫组化; 小鼠; 图 1
赛默飞世尔HLA-DRB1抗体(eBioscience, LN3)被用于被用于免疫组化在小鼠样本上 (图 1). JCI Insight (2019) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类; 图 6c
赛默飞世尔HLA-DRB1抗体(Ebioscience, 47-9956-42)被用于被用于流式细胞仪在人类样本上 (图 6c). Oncoimmunology (2019) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类; 图 3c
赛默飞世尔HLA-DRB1抗体(eBioscience, 12-9956-42)被用于被用于流式细胞仪在人类样本上 (图 3c). Cell Rep (2019) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 3c
赛默飞世尔HLA-DRB1抗体(eBioscience, 11-9952-41)被用于被用于流式细胞仪在人类样本上 (图 3c). Cell (2019) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 3a
赛默飞世尔HLA-DRB1抗体(eBioscience, L243)被用于被用于流式细胞仪在人类样本上 (图 3a). J Clin Invest (2019) ncbi
小鼠 单克隆(LN3)
  • 免疫组化; 人类; 1:1000; 图 2f
赛默飞世尔HLA-DRB1抗体(eBioscience, 14-99-56-82)被用于被用于免疫组化在人类样本上浓度为1:1000 (图 2f). Clin Exp Immunol (2018) ncbi
小鼠 单克隆(LN-3)
  • 流式细胞仪; 人类; 图 st12
赛默飞世尔HLA-DRB1抗体(eBioscience, LN3)被用于被用于流式细胞仪在人类样本上 (图 st12). Science (2017) ncbi
小鼠 单克隆(MEM-267)
  • 免疫印迹; 人类; 图 3d
赛默飞世尔HLA-DRB1抗体(Thermo Fischer Scientific, MA1-19393)被用于被用于免疫印迹在人类样本上 (图 3d). Toxicol In Vitro (2017) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类; 图 5a
赛默飞世尔HLA-DRB1抗体(eBioscience, LN3)被用于被用于流式细胞仪在人类样本上 (图 5a). Stem Cells (2017) ncbi
小鼠 单克隆(LN-3)
  • 流式细胞仪; 人类; 图 5a
赛默飞世尔HLA-DRB1抗体(eBioscience, LN3)被用于被用于流式细胞仪在人类样本上 (图 5a). Stem Cells (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 猕猴; 图 1a
赛默飞世尔HLA-DRB1抗体(Fisher Scientific, L243)被用于被用于流式细胞仪在猕猴样本上 (图 1a). J Immunol (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 1a
赛默飞世尔HLA-DRB1抗体(eBioscience, L240)被用于被用于流式细胞仪在人类样本上 (图 1a). J Clin Invest (2017) ncbi
小鼠 单克隆(LN-3)
  • 流式细胞仪; 人类; 图 4a
赛默飞世尔HLA-DRB1抗体(eBioscience, LN3)被用于被用于流式细胞仪在人类样本上 (图 4a). PLoS ONE (2016) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类; 图 1a
赛默飞世尔HLA-DRB1抗体(Invitrogen, MHLDR31)被用于被用于流式细胞仪在人类样本上 (图 1a). Rev Soc Bras Med Trop (2016) ncbi
小鼠 单克隆(T 36)
  • 流式细胞仪; 人类; 图 s2
赛默飞世尔HLA-DRB1抗体(ThermoFisher Scientific, Q22158)被用于被用于流式细胞仪在人类样本上 (图 s2). Cytometry B Clin Cytom (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DRB1抗体(eBioscience, L243)被用于被用于流式细胞仪在人类样本上. Int J Cancer (2017) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔HLA-DRB1抗体(eBioscience, 11-9956)被用于被用于流式细胞仪在人类样本上 (图 1). Stem Cell Reports (2016) ncbi
大鼠 单克隆(YD1/63.4.10)
  • 流式细胞仪; 人类; 图 4b
赛默飞世尔HLA-DRB1抗体(Thermo Fisher, MA1-70113)被用于被用于流式细胞仪在人类样本上 (图 4b). Nanomedicine (Lond) (2016) ncbi
小鼠 单克隆(T 36)
  • 流式细胞仪; 人类; 图 1a
赛默飞世尔HLA-DRB1抗体(Invitrogen, T-36)被用于被用于流式细胞仪在人类样本上 (图 1a). AIDS Res Hum Retroviruses (2016) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类; 图 2
赛默飞世尔HLA-DRB1抗体(eBioscience, 45-9956-41)被用于被用于流式细胞仪在人类样本上 (图 2). Stem Cell Reports (2016) ncbi
小鼠 单克隆(LN-3)
  • 流式细胞仪; 人类; 图 2f
赛默飞世尔HLA-DRB1抗体(Invitrogen, LN3)被用于被用于流式细胞仪在人类样本上 (图 2f). PLoS Pathog (2016) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类; 图 2f
赛默飞世尔HLA-DRB1抗体(Invitrogen, LN3)被用于被用于流式细胞仪在人类样本上 (图 2f). PLoS Pathog (2016) ncbi
小鼠 单克隆(CR3/43)
  • 免疫组化-石蜡切片; 人类; 1:1000; 图 st2
赛默飞世尔HLA-DRB1抗体(Affinity Bioreagents, CR3/43)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:1000 (图 st2). Clin Cancer Res (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 1:50; 图 s2c
赛默飞世尔HLA-DRB1抗体(ebioscience, L243)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 s2c). Nat Med (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 1:20; 图 s5j
赛默飞世尔HLA-DRB1抗体(eBioscience, 12-9952-41)被用于被用于流式细胞仪在人类样本上浓度为1:20 (图 s5j). Nat Cell Biol (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 st1
赛默飞世尔HLA-DRB1抗体(eBiosciences, L243-ef450)被用于被用于流式细胞仪在人类样本上 (图 st1). J Allergy Clin Immunol (2016) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类; 表 2
赛默飞世尔HLA-DRB1抗体(Invitrogen, VXMHLDR17)被用于被用于流式细胞仪在人类样本上 (表 2). Sci Rep (2016) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; African green monkey
赛默飞世尔HLA-DRB1抗体(eBioscience, LN3)被用于被用于流式细胞仪在African green monkey样本上. Infect Immun (2016) ncbi
小鼠 单克隆(LN-3)
  • 流式细胞仪; African green monkey
赛默飞世尔HLA-DRB1抗体(eBioscience, LN3)被用于被用于流式细胞仪在African green monkey样本上. Infect Immun (2016) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔HLA-DRB1抗体(eBioscience, LN3)被用于被用于流式细胞仪在人类样本上 (图 1). Immunol Res (2016) ncbi
小鼠 单克隆(LN-3)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔HLA-DRB1抗体(eBioscience, LN3)被用于被用于流式细胞仪在人类样本上 (图 1). Immunol Res (2016) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类; 1:200; 图 st3
赛默飞世尔HLA-DRB1抗体(eBioscience, 12-9956-42)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 st3). Leukemia (2016) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 猕猴; 图 5
赛默飞世尔HLA-DRB1抗体(生活技术, MHLDR17)被用于被用于流式细胞仪在猕猴样本上 (图 5). PLoS ONE (2015) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类; 图 3
赛默飞世尔HLA-DRB1抗体(eBioscience, LN3)被用于被用于流式细胞仪在人类样本上 (图 3). Mucosal Immunol (2016) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类; 5:100; 图 s3
赛默飞世尔HLA-DRB1抗体(eBioscience, LN3)被用于被用于流式细胞仪在人类样本上浓度为5:100 (图 s3). Nat Commun (2015) ncbi
小鼠 单克隆(LN-3)
  • 流式细胞仪; 人类; 5:100; 图 s3
赛默飞世尔HLA-DRB1抗体(eBioscience, LN3)被用于被用于流式细胞仪在人类样本上浓度为5:100 (图 s3). Nat Commun (2015) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DRB1抗体(BD, MHLDR01)被用于被用于流式细胞仪在人类样本上. Cancer Res (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DRB1抗体(eBioscience, 25-9952-41)被用于被用于流式细胞仪在人类样本上. Nanomedicine (2015) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DRB1抗体(生活技术, MHLDR01)被用于被用于流式细胞仪在人类样本上. Biochem Pharmacol (2015) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DRB1抗体(eBioscience, 11-9956)被用于被用于流式细胞仪在人类样本上. J Pediatr Surg (2014) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DRB1抗体(eBioscience, LN3)被用于被用于流式细胞仪在人类样本上. J Allergy Clin Immunol (2015) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DRB1抗体(eBioscience, LN3)被用于被用于流式细胞仪在人类样本上. Hum Immunol (2015) ncbi
小鼠 单克隆(LN3)
  • 免疫细胞化学; 人类
赛默飞世尔HLA-DRB1抗体(eBioscience, LN3)被用于被用于免疫细胞化学在人类样本上. J Immunol (2014) ncbi
小鼠 单克隆(LN-3)
  • 免疫组化-石蜡切片; 人类; 1:100; 图 2
赛默飞世尔HLA-DRB1抗体(Thermo, MA1-35420)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 2). Hum Mol Genet (2014) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DRB1抗体(eBioscience, LN3)被用于被用于流式细胞仪在人类样本上. J Exp Med (2014) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DRB1抗体(eBioscience, LN3)被用于被用于流式细胞仪在人类样本上. J Immunol (2014) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DRB1抗体(eBioscience, LN3)被用于被用于流式细胞仪在人类样本上. J Infect Dis (2014) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DRB1抗体(eBioscience, LN3)被用于被用于流式细胞仪在人类样本上. Leukemia (2014) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DRB1抗体(eBioscience, LN3)被用于被用于流式细胞仪在人类样本上. PLoS Pathog (2014) ncbi
小鼠 单克隆(CR3/43)
  • 免疫组化; 人类; 表 1
赛默飞世尔HLA-DRB1抗体(Affinity Bioreagents, MAI-25914)被用于被用于免疫组化在人类样本上 (表 1). Clin Cancer Res (2014) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类; 1:20; 图 s6
赛默飞世尔HLA-DRB1抗体(Invitrogen, Tu36)被用于被用于流式细胞仪在人类样本上浓度为1:20 (图 s6). Nat Med (2013) ncbi
小鼠 单克隆(LN-3)
  • 流式细胞仪; 人类; 图 3b
赛默飞世尔HLA-DRB1抗体(eBioscience, LN3)被用于被用于流式细胞仪在人类样本上 (图 3b). J Infect Dis (2014) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类; 图 3b
赛默飞世尔HLA-DRB1抗体(eBioscience, LN3)被用于被用于流式细胞仪在人类样本上 (图 3b). J Infect Dis (2014) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DRB1抗体(eBioscience, L243)被用于被用于流式细胞仪在人类样本上. J Hepatol (2014) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DRB1抗体(Caltag Laboratories, clone Tu36)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2013) ncbi
小鼠 单克隆(LN-3)
  • 免疫组化-石蜡切片; 猕猴; 1:50; 图 2
赛默飞世尔HLA-DRB1抗体(生活技术, LN3)被用于被用于免疫组化-石蜡切片在猕猴样本上浓度为1:50 (图 2). PLoS ONE (2013) ncbi
小鼠 单克隆(LN3)
  • 免疫组化-石蜡切片; 猕猴; 1:50; 图 2
赛默飞世尔HLA-DRB1抗体(生活技术, LN3)被用于被用于免疫组化-石蜡切片在猕猴样本上浓度为1:50 (图 2). PLoS ONE (2013) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 猕猴; 图 2a
赛默飞世尔HLA-DRB1抗体(Invitrogen, TU36)被用于被用于流式细胞仪在猕猴样本上 (图 2a). Hum Vaccin Immunother (2012) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DRB1抗体(Caltag Laboratories, MHLDR05)被用于被用于流式细胞仪在人类样本上. J Leukoc Biol (2012) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 S2
赛默飞世尔HLA-DRB1抗体(eBioscience, 48-9952-42)被用于被用于流式细胞仪在人类样本上 (图 S2). Proc Natl Acad Sci U S A (2012) ncbi
小鼠 单克隆(LN-3)
  • 免疫组化-石蜡切片; 猕猴; 1:200; 表 2
  • 流式细胞仪; 猕猴; 图 7
赛默飞世尔HLA-DRB1抗体(Zymed Laboratory, clone LN-3)被用于被用于免疫组化-石蜡切片在猕猴样本上浓度为1:200 (表 2) 和 被用于流式细胞仪在猕猴样本上 (图 7). J Pathol (2008) ncbi
小鼠 单克隆(LN3)
  • 免疫组化-石蜡切片; 猕猴; 1:200; 表 2
  • 流式细胞仪; 猕猴; 图 7
赛默飞世尔HLA-DRB1抗体(Zymed Laboratory, clone LN-3)被用于被用于免疫组化-石蜡切片在猕猴样本上浓度为1:200 (表 2) 和 被用于流式细胞仪在猕猴样本上 (图 7). J Pathol (2008) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类; 1:50
赛默飞世尔HLA-DRB1抗体(Caltag, MHLDR04)被用于被用于流式细胞仪在人类样本上浓度为1:50. Methods Mol Biol (2007) ncbi
小鼠 单克隆(TU36)
  • 免疫组化; 人类; 图 2
赛默飞世尔HLA-DRB1抗体(Caltag, MHLDR01)被用于被用于免疫组化在人类样本上 (图 2). Immunology (2004) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DRB1抗体(Caltag, TU36)被用于被用于流式细胞仪在人类样本上. Pediatr Res (2004) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DRB1抗体(Caltag, TU36)被用于被用于流式细胞仪在人类样本上. Cytometry B Clin Cytom (2003) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类; 图 4
赛默飞世尔HLA-DRB1抗体(Caltag, TU36)被用于被用于流式细胞仪在人类样本上 (图 4). J Virol (2003) ncbi
小鼠 单克隆(LN-3)
  • 免疫组化-冰冻切片; 人类; 图 6
  • 流式细胞仪; 人类; 图 4
赛默飞世尔HLA-DRB1抗体(Zymed, LN-3)被用于被用于免疫组化-冰冻切片在人类样本上 (图 6) 和 被用于流式细胞仪在人类样本上 (图 4). Int Immunol (2002) ncbi
小鼠 单克隆(LN3)
  • 免疫组化-冰冻切片; 人类; 图 6
  • 流式细胞仪; 人类; 图 4
赛默飞世尔HLA-DRB1抗体(Zymed, LN-3)被用于被用于免疫组化-冰冻切片在人类样本上 (图 6) 和 被用于流式细胞仪在人类样本上 (图 4). Int Immunol (2002) ncbi
小鼠 单克隆(HL-38)
  • 流式细胞仪; 人类; 4 ug/ml
赛默飞世尔HLA-DRB1抗体(Caltag, HL38)被用于被用于流式细胞仪在人类样本上浓度为4 ug/ml. Blood (2001) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DRB1抗体(Caltag, TU 36)被用于被用于流式细胞仪在人类样本上. Infect Immun (2000) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DRB1抗体(Caltag, TU36)被用于被用于流式细胞仪在人类样本上. Br J Haematol (1999) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DRB1抗体(Caltag, TU36)被用于被用于流式细胞仪在人类样本上. Proc Natl Acad Sci U S A (1999) ncbi
小鼠 单克隆(HL-38)
  • 流式细胞仪; 人类; 图 3
赛默飞世尔HLA-DRB1抗体(Caltag, HL38)被用于被用于流式细胞仪在人类样本上 (图 3). Blood (1997) ncbi
小鼠 单克隆(HL-38)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DRB1抗体(Caltag, HL38)被用于被用于流式细胞仪在人类样本上. J Clin Invest (1997) ncbi
美天旎
人类 单克隆(REA332)
  • 流式细胞仪; 人类; 1:200; 图 2s1a
美天旎HLA-DRB1抗体(Miltenyi Biotec, REA332)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 2s1a). elife (2020) ncbi
小鼠 单克隆(AC122)
  • 流式细胞仪; 人类; 图 4c
美天旎HLA-DRB1抗体(Miltenyi Biotec, AC122)被用于被用于流式细胞仪在人类样本上 (图 4c). Cell Death Dis (2019) ncbi
人类 单克隆(REA332)
  • 流式细胞仪; 人类; 图 s3j
美天旎HLA-DRB1抗体(Miltenyi Biotec, REA332)被用于被用于流式细胞仪在人类样本上 (图 s3j). Biol Blood Marrow Transplant (2018) ncbi
人类 单克隆(REA332)
  • 流式细胞仪; 人类; 图 st1
美天旎HLA-DRB1抗体(Miltenyi, REA332)被用于被用于流式细胞仪在人类样本上 (图 st1). Front Immunol (2017) ncbi
人类 单克隆(REA332)
  • 流式细胞仪; 人类; 1:20; 图 6a
美天旎HLA-DRB1抗体(Miltenyi Biotec, REA332)被用于被用于流式细胞仪在人类样本上浓度为1:20 (图 6a). J Immunol (2017) ncbi
人类 单克隆(REA332)
  • 流式细胞仪; 人类; 图 1a
美天旎HLA-DRB1抗体(Miltenyi Biotec, REA332)被用于被用于流式细胞仪在人类样本上 (图 1a). Eur J Pharm Biopharm (2017) ncbi
人类 单克隆(REA332)
  • 流式细胞仪; 人类; 图 1
美天旎HLA-DRB1抗体(Miltenyi Biotec, REA332)被用于被用于流式细胞仪在人类样本上 (图 1). Inflammation (2016) ncbi
圣克鲁斯生物技术
小鼠 单克隆(DA2)
  • 免疫印迹; 人类; 图 2b
圣克鲁斯生物技术HLA-DRB1抗体(Santa Cruz Biotechnology, DA2)被用于被用于免疫印迹在人类样本上 (图 2b). J Immunol (2019) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 1:50; 图 1
圣克鲁斯生物技术HLA-DRB1抗体(Santa Cruz, sc-18875)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 1). Stem Cell Res Ther (2016) ncbi
小鼠 单克隆(ML11C11)
  • 免疫组化-石蜡切片; 人类; 1:50; 图 1
圣克鲁斯生物技术HLA-DRB1抗体(santa Cruz, sc-73366)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:50 (图 1). PLoS ONE (2016) ncbi
小鼠 单克隆(TAL 14.1)
  • 免疫沉淀; 小鼠
圣克鲁斯生物技术HLA-DRB1抗体(Santa Cruz Biotechnology, TAL 14.1)被用于被用于免疫沉淀在小鼠样本上. J Biol Chem (2015) ncbi
文章列表
  1. Morrissey M, Byrne R, Nulty C, McCabe N, Lynam Lennon N, Butler C, et al. The tumour microenvironment of the upper and lower gastrointestinal tract differentially influences dendritic cell maturation. BMC Cancer. 2020;20:566 pubmed 出版商
  2. Ma T, Luo X, George A, Mukherjee G, Sen N, Spitzer T, et al. HIV efficiently infects T cells from the endometrium and remodels them to promote systemic viral spread. elife. 2020;9: pubmed 出版商
  3. Park J, Botting R, Domínguez Conde C, Popescu D, Lavaert M, Kunz D, et al. A cell atlas of human thymic development defines T cell repertoire formation. Science. 2020;367: pubmed 出版商
  4. Mosaheb M, Dobrikova E, Brown M, Yang Y, Cable J, Okada H, et al. Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity. Nat Commun. 2020;11:524 pubmed 出版商
  5. Shnayder M, Nachshon A, Rozman B, Bernshtein B, Lavi M, Fein N, et al. Single cell analysis reveals human cytomegalovirus drives latently infected cells towards an anergic-like monocyte state. elife. 2020;9: pubmed 出版商
  6. Helmink B, Reddy S, Gao J, Zhang S, Basar R, Thakur R, et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature. 2020;577:549-555 pubmed 出版商
  7. Uhlen M, Karlsson M, Zhong W, Tebani A, Pou C, Mikes J, et al. A genome-wide transcriptomic analysis of protein-coding genes in human blood cells. Science. 2019;366: pubmed 出版商
  8. Raphael I, Gomez Rivera F, Raphael R, Robinson R, Nalawade S, Forsthuber T. TNFR2 limits proinflammatory astrocyte functions during EAE induced by pathogenic DR2b-restricted T cells. JCI Insight. 2019;4: pubmed 出版商
  9. Leylek R, Alcántara Hernández M, Lanzar Z, Lüdtke A, Perez O, Reizis B, et al. Integrated Cross-Species Analysis Identifies a Conserved Transitional Dendritic Cell Population. Cell Rep. 2019;29:3736-3750.e8 pubmed 出版商
  10. Yan D, Wang J, Sun H, Zamani A, Zhang H, Chen W, et al. TIPE2 specifies the functional polarization of myeloid-derived suppressor cells during tumorigenesis. J Exp Med. 2020;217: pubmed 出版商
  11. Stewart B, Ferdinand J, Young M, Mitchell T, Loudon K, Riding A, et al. Spatiotemporal immune zonation of the human kidney. Science. 2019;365:1461-1466 pubmed 出版商
  12. Ramachandran P, Dobie R, Wilson Kanamori J, Dora E, Henderson B, Luu N, et al. Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature. 2019;575:512-518 pubmed 出版商
  13. Merola J, Reschke M, Pierce R, Qin L, Spindler S, Baltazar T, et al. Progenitor-derived human endothelial cells evade alloimmunity by CRISPR/Cas9-mediated complete ablation of MHC expression. JCI Insight. 2019;4: pubmed 出版商
  14. Dutertre C, Becht E, Irac S, Khalilnezhad A, Narang V, Khalilnezhad S, et al. Single-Cell Analysis of Human Mononuclear Phagocytes Reveals Subset-Defining Markers and Identifies Circulating Inflammatory Dendritic Cells. Immunity. 2019;51:573-589.e8 pubmed 出版商
  15. Martin J, Chang C, Boschetti G, Ungaro R, Giri M, Grout J, et al. Single-Cell Analysis of Crohn's Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy. Cell. 2019;178:1493-1508.e20 pubmed 出版商
  16. Saliba D, Céspedes Donoso P, Balint S, Compeer E, Korobchevskaya K, Valvo S, et al. Composition and structure of synaptic ectosomes exporting antigen receptor linked to functional CD40 ligand from helper T cells. elife. 2019;8: pubmed 出版商
  17. Di Blasi D, Boldanova T, Mori L, Terracciano L, Heim M, De Libero G. Unique T-Cell Populations Define Immune-Inflamed Hepatocellular Carcinoma. Cell Mol Gastroenterol Hepatol. 2020;9:195-218 pubmed 出版商
  18. Findlay E, Currie A, Zhang A, Ovciarikova J, Young L, Stevens H, et al. Exposure to the antimicrobial peptide LL-37 produces dendritic cells optimized for immunotherapy. Oncoimmunology. 2019;8:1608106 pubmed 出版商
  19. Dumont A, de Rosny C, Kieu T, Perrey S, Berger H, Fluckiger A, et al. Docosahexaenoic acid inhibits both NLRP3 inflammasome assembly and JNK-mediated mature IL-1β secretion in 5-fluorouracil-treated MDSC: implication in cancer treatment. Cell Death Dis. 2019;10:485 pubmed 出版商
  20. Xia Y, Gao Y, Wang B, Zhang H, Zhang Q. Optimizing the Method of Cell Separation from Bile of Patients with Cholangiocarcinoma for Flow Cytometry. Gastroenterol Res Pract. 2019;2019:5436961 pubmed 出版商
  21. Celis Gutierrez J, Blattmann P, Zhai Y, Jarmuzynski N, Ruminski K, Gregoire C, et al. Quantitative Interactomics in Primary T Cells Provides a Rationale for Concomitant PD-1 and BTLA Coinhibitor Blockade in Cancer Immunotherapy. Cell Rep. 2019;27:3315-3330.e7 pubmed 出版商
  22. Dangaj D, Bruand M, Grimm A, Ronet C, Barras D, Duttagupta P, et al. Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors. Cancer Cell. 2019;35:885-900.e10 pubmed 出版商
  23. Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck W, et al. Comprehensive Integration of Single-Cell Data. Cell. 2019;: pubmed 出版商
  24. Swaims Kohlmeier A, Haddad L, Li Z, Brookmeyer K, Baker J, Widom C, et al. Chronic immune barrier dysregulation among women with a history of violence victimization. JCI Insight. 2019;4: pubmed 出版商
  25. Fernandez I, Baxter R, Garcia Perez J, Vendrame E, Ranganath T, Kong D, et al. A novel human IL2RB mutation results in T and NK cell-driven immune dysregulation. J Exp Med. 2019;216:1255-1267 pubmed 出版商
  26. Zhang J, Supakorndej T, Krambs J, Rao M, Abou Ezzi G, Ye R, et al. Bone marrow dendritic cells regulate hematopoietic stem/progenitor cell trafficking. J Clin Invest. 2019;129:2920-2931 pubmed 出版商
  27. Terahara K, Iwabuchi R, Hosokawa M, Nishikawa Y, Takeyama H, Takahashi Y, et al. A CCR5+ memory subset within HIV-1-infected primary resting CD4+ T cells is permissive for replication-competent, latently infected viruses in vitro. BMC Res Notes. 2019;12:242 pubmed 出版商
  28. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed 出版商
  29. Cassetta L, Fragkogianni S, Sims A, Swierczak A, Forrester L, Zhang H, et al. Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets. Cancer Cell. 2019;35:588-602.e10 pubmed 出版商
  30. Sweere J, Van Belleghem J, Ishak H, Bach M, Popescu M, Sunkari V, et al. Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection. Science. 2019;363: pubmed 出版商
  31. Chakarov S, Lim H, Tan L, Lim S, See P, Lum J, et al. Two distinct interstitial macrophage populations coexist across tissues in specific subtissular niches. Science. 2019;363: pubmed 出版商
  32. Crippa S, Rossella V, Aprile A, Silvestri L, Rivis S, Scaramuzza S, et al. Bone marrow stromal cells from β-thalassemia patients have impaired hematopoietic supportive capacity. J Clin Invest. 2019;129:1566-1580 pubmed 出版商
  33. Georgouli M, Herraiz C, Crosas Molist E, Fanshawe B, Maiques O, Perdrix A, et al. Regional Activation of Myosin II in Cancer Cells Drives Tumor Progression via a Secretory Cross-Talk with the Immune Microenvironment. Cell. 2019;176:757-774.e23 pubmed 出版商
  34. Crivello P, Ahci M, Maaßen F, Wossidlo N, Arrieta Bolaños E, Heinold A, et al. Multiple Knockout of Classical HLA Class II β-Chains by CRISPR/Cas9 Genome Editing Driven by a Single Guide RNA. J Immunol. 2019;202:1895-1903 pubmed 出版商
  35. Jin Y, Roberts G, Ferrara T, Ben S, van Geel N, Wolkerstorfer A, et al. Early-onset autoimmune vitiligo associated with an enhancer variant haplotype that upregulates class II HLA expression. Nat Commun. 2019;10:391 pubmed 出版商
  36. Alam M, Yang D, Trivett A, Meyer T, Oppenheim J. HMGN1 and R848 Synergistically Activate Dendritic Cells Using Multiple Signaling Pathways. Front Immunol. 2018;9:2982 pubmed 出版商
  37. Richardson J, Armbruster N, Günter M, Henes J, Autenrieth S. Staphylococcus aureus PSM Peptides Modulate Human Monocyte-Derived Dendritic Cells to Prime Regulatory T Cells. Front Immunol. 2018;9:2603 pubmed 出版商
  38. Jones G, Bain C, Fenton T, Kelly A, Brown S, Ivens A, et al. Dynamics of Colon Monocyte and Macrophage Activation During Colitis. Front Immunol. 2018;9:2764 pubmed 出版商
  39. Ding L, Kim H, Wang Q, Kearns M, Jiang T, Ohlson C, et al. PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer. Cell Rep. 2018;25:2972-2980.e5 pubmed 出版商
  40. Poncette L, Chen X, Lorenz F, Blankenstein T. Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression. J Clin Invest. 2019;129:324-335 pubmed 出版商
  41. Perciani C, Farah B, Kaul R, Ostrowski M, Mahmud S, Anzala O, et al. Live attenuated varicella-zoster virus vaccine does not induce HIV target cell activation. J Clin Invest. 2019;129:875-886 pubmed 出版商
  42. Kelly A, Günaltay S, McEntee C, Shuttleworth E, Smedley C, Houston S, et al. Human monocytes and macrophages regulate immune tolerance via integrin αvβ8-mediated TGFβ activation. J Exp Med. 2018;215:2725-2736 pubmed 出版商
  43. Otsuka Y, Watanabe E, Shinya E, Okura S, Saeki H, Geijtenbeek T, et al. Differentiation of Langerhans Cells from Monocytes and Their Specific Function in Inducing IL-22-Specific Th Cells. J Immunol. 2018;201:3006-3016 pubmed 出版商
  44. Olin A, Henckel E, Chen Y, Lakshmikanth T, Pou C, Mikes J, et al. Stereotypic Immune System Development in Newborn Children. Cell. 2018;174:1277-1292.e14 pubmed 出版商
  45. Kong X, Martinez Barricarte R, Kennedy J, Mele F, Lazarov T, Deenick E, et al. Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency. Nat Immunol. 2018;19:973-985 pubmed 出版商
  46. Walwyn Brown K, Guldevall K, Saeed M, Pende D, Önfelt B, MacDonald A, et al. Human NK Cells Lyse Th2-Polarizing Dendritic Cells via NKp30 and DNAM-1. J Immunol. 2018;201:2028-2041 pubmed 出版商
  47. Gorter R, Nutma E, Jahrei M, de Jonge J, Quinlan R, van der Valk P, et al. Heat shock proteins are differentially expressed in brain and spinal cord: implications for multiple sclerosis. Clin Exp Immunol. 2018;194:137-152 pubmed 出版商
  48. Arnold I, Artola Borán M, Tallón de Lara P, Kyburz A, Taube C, OTTEMANN K, et al. Eosinophils suppress Th1 responses and restrict bacterially induced gastrointestinal inflammation. J Exp Med. 2018;215:2055-2072 pubmed 出版商
  49. Alissafi T, Hatzioannou A, Mintzas K, Barouni R, Banos A, Sormendi S, et al. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells. J Clin Invest. 2018;128:3840-3852 pubmed 出版商
  50. Dumbovic G, Biayna J, Banús J, Samuelsson J, Roth A, Diederichs S, et al. A novel long non-coding RNA from NBL2 pericentromeric macrosatellite forms a perinucleolar aggregate structure in colon cancer. Nucleic Acids Res. 2018;46:5504-5524 pubmed 出版商
  51. Fan X, Guo D, Cheung A, Poon Z, Yap C, Goh S, et al. Mesenchymal Stromal Cell (MSC)-Derived Combination of CXCL5 and Anti-CCL24 Is Synergistic and Superior to MSC and Cyclosporine for the Treatment of Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2018;24:1971-1980 pubmed 出版商
  52. Zacharakis N, Chinnasamy H, Black M, Xu H, Lu Y, Zheng Z, et al. Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer. Nat Med. 2018;24:724-730 pubmed 出版商
  53. Melo Gonzalez F, Fenton T, Forss C, Smedley C, Goenka A, MacDonald A, et al. Intestinal mucin activates human dendritic cells and IL-8 production in a glycan-specific manner. J Biol Chem. 2018;293:8543-8553 pubmed 出版商
  54. Li M, Zhang W, Liu J, Li M, Zhang Y, Xiong Y, et al. Dynamic changes in the immunological characteristics of T lymphocytes in surviving patients with severe fever with thrombocytopenia syndrome (SFTS). Int J Infect Dis. 2018;70:72-80 pubmed 出版商
  55. Liu R, Merola J, Manes T, Qin L, Tietjen G, Lopez Giraldez F, et al. Interferon-γ converts human microvascular pericytes into negative regulators of alloimmunity through induction of indoleamine 2,3-dioxygenase 1. JCI Insight. 2018;3: pubmed 出版商
  56. Fujisaka Y, Iwata T, Tamai K, Nakamura M, Mochizuki M, Shibuya R, et al. Long non-coding RNA HOTAIR up-regulates chemokine (C-C motif) ligand 2 and promotes proliferation of macrophages and myeloid-derived suppressor cells in hepatocellular carcinoma cell lines. Oncol Lett. 2018;15:509-514 pubmed 出版商
  57. Bujko A, Atlasy N, Landsverk O, Richter L, Yaqub S, Horneland R, et al. Transcriptional and functional profiling defines human small intestinal macrophage subsets. J Exp Med. 2018;215:441-458 pubmed 出版商
  58. Delso Vallejo M, Kollet J, Koehl U, Huppert V. Influence of Irradiated Peripheral Blood Mononuclear Cells on Both Ex Vivo Proliferation of Human Natural Killer Cells and Change in Cellular Property. Front Immunol. 2017;8:854 pubmed 出版商
  59. Chew V, Lai L, Pan L, Lim C, Li J, Ong R, et al. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses. Proc Natl Acad Sci U S A. 2017;114:E5900-E5909 pubmed 出版商
  60. Gosselin D, Skola D, Coufal N, Holtman I, Schlachetzki J, Sajti E, et al. An environment-dependent transcriptional network specifies human microglia identity. Science. 2017;356: pubmed 出版商
  61. Chevrier S, Levine J, Zanotelli V, Silina K, Schulz D, Bacac M, et al. An Immune Atlas of Clear Cell Renal Cell Carcinoma. Cell. 2017;169:736-749.e18 pubmed 出版商
  62. See P, Dutertre C, Chen J, Günther P, McGovern N, Irac S, et al. Mapping the human DC lineage through the integration of high-dimensional techniques. Science. 2017;356: pubmed 出版商
  63. Pryke K, Abraham J, Sali T, Gall B, Archer I, Liu A, et al. A Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory to Replication of Zika, Chikungunya, and Dengue Viruses. MBio. 2017;8: pubmed 出版商
  64. Villani A, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science. 2017;356: pubmed 出版商
  65. Zhang J, Xu X, Shi M, Chen Y, Yu D, Zhao C, et al. CD13hi Neutrophil-like myeloid-derived suppressor cells exert immune suppression through Arginase 1 expression in pancreatic ductal adenocarcinoma. Oncoimmunology. 2017;6:e1258504 pubmed 出版商
  66. Borriello F, Iannone R, Di Somma S, Vastolo V, Petrosino G, Visconte F, et al. Lipopolysaccharide-Elicited TSLPR Expression Enriches a Functionally Discrete Subset of Human CD14+ CD1c+ Monocytes. J Immunol. 2017;198:3426-3435 pubmed 出版商
  67. Mytych J, Romerowicz Misielak M, Koziorowski M. Long-term culture with lipopolysaccharide induces dose-dependent cytostatic and cytotoxic effects in THP-1 monocytes. Toxicol In Vitro. 2017;42:1-9 pubmed 出版商
  68. Seif M, Hoppstädter J, Breinig F, Kiemer A. Yeast-mediated mRNA delivery polarizes immuno-suppressive macrophages towards an immuno-stimulatory phenotype. Eur J Pharm Biopharm. 2017;117:1-13 pubmed 出版商
  69. Smith N, Pietrancosta N, Davidson S, Dutrieux J, Chauveau L, Cutolo P, et al. Natural amines inhibit activation of human plasmacytoid dendritic cells through CXCR4 engagement. Nat Commun. 2017;8:14253 pubmed 出版商
  70. O CONNOR D, Clutterbuck E, Thompson A, Snape M, Ramasamy M, Kelly D, et al. High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine. Genome Med. 2017;9:11 pubmed 出版商
  71. Sontag S, Förster M, Qin J, Wanek P, Mitzka S, Schüler H, et al. Modelling IRF8 Deficient Human Hematopoiesis and Dendritic Cell Development with Engineered iPS Cells. Stem Cells. 2017;35:898-908 pubmed 出版商
  72. Dross S, Munson P, Kim S, Bratt D, Tunggal H, Gervassi A, et al. Kinetics of Myeloid-Derived Suppressor Cell Frequency and Function during Simian Immunodeficiency Virus Infection, Combination Antiretroviral Therapy, and Treatment Interruption. J Immunol. 2017;198:757-766 pubmed 出版商
  73. Cheng L, Ma J, Li J, Li D, Li G, Li F, et al. Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs. J Clin Invest. 2017;127:269-279 pubmed 出版商
  74. Zhen A, Rezek V, Youn C, Lam B, Chang N, Rick J, et al. Targeting type I interferon-mediated activation restores immune function in chronic HIV infection. J Clin Invest. 2017;127:260-268 pubmed 出版商
  75. Kasturi S, Kozlowski P, Nakaya H, Burger M, Russo P, Pham M, et al. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques. J Virol. 2017;91: pubmed 出版商
  76. Gouwy M, Ruytinx P, Radice E, Claudi F, Van Raemdonck K, Bonecchi R, et al. CXCL4 and CXCL4L1 Differentially Affect Monocyte Survival and Dendritic Cell Differentiation and Phagocytosis. PLoS ONE. 2016;11:e0166006 pubmed 出版商
  77. Soares A, Neves P, Cavalcanti M, Marinho S, Oliveira W, Souza J, et al. Expression of co-stimulatory molecules CD80 and CD86 is altered in CD14 + HLA-DR + monocytes from patients with Chagas disease following induction by Trypanosoma cruzi recombinant antigens. Rev Soc Bras Med Trop. 2016;49:632-636 pubmed 出版商
  78. Yao Y, Welp T, Liu Q, Niu N, Wang X, Britto C, et al. Multiparameter Single Cell Profiling of Airway Inflammatory Cells. Cytometry B Clin Cytom. 2017;92:12-20 pubmed 出版商
  79. Sumatoh H, Teng K, Cheng Y, Newell E. Optimization of mass cytometry sample cryopreservation after staining. Cytometry A. 2017;91:48-61 pubmed 出版商
  80. Nagase H, Takeoka T, Urakawa S, Morimoto Okazawa A, Kawashima A, Iwahori K, et al. ICOS+ Foxp3+ TILs in gastric cancer are prognostic markers and effector regulatory T cells associated with Helicobacter pylori. Int J Cancer. 2017;140:686-695 pubmed 出版商
  81. Misra S, Selvam A, Wallenberg M, Ambati A, Matolcsy A, Magalhaes I, et al. Selenite promotes all-trans retinoic acid-induced maturation of acute promyelocytic leukemia cells. Oncotarget. 2016;7:74686-74700 pubmed 出版商
  82. Wang Y, Ma C, Ling Y, Bousfiha A, Camcioglu Y, Jacquot S, et al. Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations. J Exp Med. 2016;213:2413-2435 pubmed
  83. Sugita S, Iwasaki Y, Makabe K, Kimura T, Futagami T, Suegami S, et al. Lack of T Cell Response to iPSC-Derived Retinal Pigment Epithelial Cells from HLA Homozygous Donors. Stem Cell Reports. 2016;7:619-634 pubmed 出版商
  84. Foerster F, Bamberger D, Schupp J, Weilbächer M, Kaps L, Strobl S, et al. Dextran-based therapeutic nanoparticles for hepatic drug delivery. Nanomedicine (Lond). 2016;11:2663-2677 pubmed
  85. Keefer M, Zheng B, Rosenberg A, Kobie J. Increased Steady-State Memory B Cell Subsets Among High-Risk Participants in an HIV Vaccine Trial. AIDS Res Hum Retroviruses. 2016;32:1143-1148 pubmed
  86. Deng Y, Cheng J, Fu B, Liu W, Chen G, Zhang Q, et al. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells. Oncogene. 2017;36:1090-1101 pubmed 出版商
  87. Greco S, Torres Hernandez A, Kalabin A, Whiteman C, Rokosh R, Ravirala S, et al. Mincle Signaling Promotes Con A Hepatitis. J Immunol. 2016;197:2816-27 pubmed 出版商
  88. van Erp F, Knol E, Pontoppidan B, Meijer Y, van der Ent C, Knulst A. The IgE and basophil responses to Ara h 2 and Ara h 6 are good predictors of peanut allergy in children. J Allergy Clin Immunol. 2017;139:358-360.e8 pubmed 出版商
  89. Yao Y, Deng Q, Song W, Zhang H, Li Y, Yang Y, et al. MIF Plays a Key Role in Regulating Tissue-Specific Chondro-Osteogenic Differentiation Fate of Human Cartilage Endplate Stem Cells under Hypoxia. Stem Cell Reports. 2016;7:249-62 pubmed 出版商
  90. Xing Y, Cao R, Hu H. TLR and NLRP3 inflammasome-dependent innate immune responses to tumor-derived autophagosomes (DRibbles). Cell Death Dis. 2016;7:e2322 pubmed 出版商
  91. Demers K, Makedonas G, Buggert M, Eller M, Ratcliffe S, Goonetilleke N, et al. Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection. PLoS Pathog. 2016;12:e1005805 pubmed 出版商
  92. Cerny D, Thi Le D, The T, Zuest R, Kg S, Velumani S, et al. Complete human CD1a deficiency on Langerhans cells due to a rare point mutation in the coding sequence. J Allergy Clin Immunol. 2016;138:1709-1712.e11 pubmed 出版商
  93. Rölle A, Halenius A, Ewen E, Cerwenka A, Hengel H, Momburg F. CD2-CD58 interactions are pivotal for the activation and function of adaptive natural killer cells in human cytomegalovirus infection. Eur J Immunol. 2016;46:2420-2425 pubmed 出版商
  94. Seif M, Philippi A, Breinig F, Kiemer A, Hoppstädter J. Yeast (Saccharomyces cerevisiae) Polarizes Both M-CSF- and GM-CSF-Differentiated Macrophages Toward an M1-Like Phenotype. Inflammation. 2016;39:1690-703 pubmed 出版商
  95. Wittmann A, Lamprinaki D, Bowles K, Katzenellenbogen E, Knirel Y, Whitfield C, et al. Dectin-2 Recognizes Mannosylated O-antigens of Human Opportunistic Pathogens and Augments Lipopolysaccharide Activation of Myeloid Cells. J Biol Chem. 2016;291:17629-38 pubmed 出版商
  96. Booth J, Duggan E, Patel V, Langer M, Wu W, Braun A, et al. Bacillus anthracis spore movement does not require a carrier cell and is not affected by lethal toxin in human lung models. Microbes Infect. 2016;18:615-626 pubmed 出版商
  97. Gadd V, Patel P, Jose S, Horsfall L, Powell E, Irvine K. Altered Peripheral Blood Monocyte Phenotype and Function in Chronic Liver Disease: Implications for Hepatic Recruitment and Systemic Inflammation. PLoS ONE. 2016;11:e0157771 pubmed 出版商
  98. Tomasello L, Musso R, Cillino G, Pitrone M, Pizzolanti G, Coppola A, et al. Donor age and long-term culture do not negatively influence the stem potential of limbal fibroblast-like stem cells. Stem Cell Res Ther. 2016;7:83 pubmed 出版商
  99. Zanetti S, Ziblat A, Torres N, Zwirner N, Bouzat C. Expression and Functional Role of ?7 Nicotinic Receptor in Human Cytokine-stimulated Natural Killer (NK) Cells. J Biol Chem. 2016;291:16541-52 pubmed 出版商
  100. Wang Z, Milne K, Derocher H, Webb J, Nelson B, Watson P. CD103 and Intratumoral Immune Response in Breast Cancer. Clin Cancer Res. 2016;22:6290-6297 pubmed
  101. Reinisch A, Thomas D, Corces M, Zhang X, Gratzinger D, Hong W, et al. A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells. Nat Med. 2016;22:812-21 pubmed 出版商
  102. Welte T, Kim I, Tian L, Gao X, Wang H, Li J, et al. Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation. Nat Cell Biol. 2016;18:632-44 pubmed 出版商
  103. Rai V, Rao V, Shao Z, Agrawal D. Dendritic Cells Expressing Triggering Receptor Expressed on Myeloid Cells-1 Correlate with Plaque Stability in Symptomatic and Asymptomatic Patients with Carotid Stenosis. PLoS ONE. 2016;11:e0154802 pubmed 出版商
  104. Ruibal P, Oestereich L, Lüdtke A, Becker Ziaja B, Wozniak D, Kerber R, et al. Unique human immune signature of Ebola virus disease in Guinea. Nature. 2016;533:100-4 pubmed 出版商
  105. Li H, Borrego F, Nagata S, Tolnay M. Fc Receptor-like 5 Expression Distinguishes Two Distinct Subsets of Human Circulating Tissue-like Memory B Cells. J Immunol. 2016;196:4064-74 pubmed 出版商
  106. Zwang N, Zhang R, Germana S, Fan M, Hastings W, Cao A, et al. Selective Sparing of Human Tregs by Pharmacologic Inhibitors of the Phosphatidylinositol 3-Kinase and MEK Pathways. Am J Transplant. 2016;16:2624-38 pubmed 出版商
  107. Leone D, Kozakowski N, Kornauth C, Waidacher T, Neudert B, Loeffler A, et al. The Phenotypic Characterization of the Human Renal Mononuclear Phagocytes Reveal a Co-Ordinated Response to Injury. PLoS ONE. 2016;11:e0151674 pubmed 出版商
  108. Leitch C, Natafji E, Yu C, Abdul Ghaffar S, Madarasingha N, Venables Z, et al. Filaggrin-null mutations are associated with increased maturation markers on Langerhans cells. J Allergy Clin Immunol. 2016;138:482-490.e7 pubmed 出版商
  109. Zondler L, Müller K, Khalaji S, Bliederhäuser C, Ruf W, Grozdanov V, et al. Peripheral monocytes are functionally altered and invade the CNS in ALS patients. Acta Neuropathol. 2016;132:391-411 pubmed 出版商
  110. Hogan L, Jones D, Allen R. Expression of the innate immune receptor LILRB5 on monocytes is associated with mycobacteria exposure. Sci Rep. 2016;6:21780 pubmed 出版商
  111. Phuah J, Wong E, Gideon H, Maiello P, Coleman M, Hendricks M, et al. Effects of B Cell Depletion on Early Mycobacterium tuberculosis Infection in Cynomolgus Macaques. Infect Immun. 2016;84:1301-1311 pubmed 出版商
  112. Srivastava P, Paluch B, Matsuzaki J, James S, Collamat Lai G, Blagitko Dorfs N, et al. Induction of cancer testis antigen expression in circulating acute myeloid leukemia blasts following hypomethylating agent monotherapy. Oncotarget. 2016;7:12840-56 pubmed 出版商
  113. Johnson D, Estrada M, Salgado R, Sanchez V, Doxie D, Opalenik S, et al. Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy. Nat Commun. 2016;7:10582 pubmed 出版商
  114. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed 出版商
  115. Younis R, Han K, Webb T. Human Head and Neck Squamous Cell Carcinoma-Associated Semaphorin 4D Induces Expansion of Myeloid-Derived Suppressor Cells. J Immunol. 2016;196:1419-29 pubmed 出版商
  116. Gonzalez S, Taborda N, Correa L, Castro G, Hernandez J, Montoya C, et al. Particular activation phenotype of T cells expressing HLA-DR but not CD38 in GALT from HIV-controllers is associated with immune regulation and delayed progression to AIDS. Immunol Res. 2016;64:765-74 pubmed 出版商
  117. Brown P, Wong K, Felce S, Lyne L, Spearman H, Soilleux E, et al. FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas. Leukemia. 2016;30:605-16 pubmed 出版商
  118. Byrareddy S, Little D, Mayne A, Villinger F, Ansari A. Phenotypic and Functional Characterization of Monoclonal Antibodies with Specificity for Rhesus Macaque CD200, CD200R and Mincle. PLoS ONE. 2015;10:e0140689 pubmed 出版商
  119. Schulz A, Mälzer J, Domingo C, Jürchott K, Grützkau A, Babel N, et al. Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans. J Immunol. 2015;195:4699-711 pubmed 出版商
  120. McCausland M, Juchnowski S, Zidar D, Kuritzkes D, Andrade A, Sieg S, et al. Altered Monocyte Phenotype in HIV-1 Infection Tends to Normalize with Integrase-Inhibitor-Based Antiretroviral Therapy. PLoS ONE. 2015;10:e0139474 pubmed 出版商
  121. Rosario M, Liu B, Kong L, Collins L, Schneider S, Chen X, et al. The IL-15-Based ALT-803 Complex Enhances FcγRIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell Lymphomas. Clin Cancer Res. 2016;22:596-608 pubmed 出版商
  122. Frederiksen J, Buggert M, Noyan K, Nowak P, Sönnerborg A, Lund O, et al. Multidimensional Clusters of CD4+ T Cell Dysfunction Are Primarily Associated with the CD4/CD8 Ratio in Chronic HIV Infection. PLoS ONE. 2015;10:e0137635 pubmed 出版商
  123. Denkovskij J, Rudys R, Bernotiene E, Minderis M, Bagdonas S, Kirdaite G. Cell surface markers and exogenously induced PpIX in synovial mesenchymal stem cells. Cytometry A. 2015;87:1001-11 pubmed 出版商
  124. Li X, Liu X, Zhao Y, Zhong R, Song A, Sun L. Effect of thymosin α₁ on the phenotypic and functional maturation of dendritic cells from children with acute lymphoblastic leukemia. Mol Med Rep. 2015;12:6093-7 pubmed 出版商
  125. Pojero F, Flores Montero J, Sanoja L, Pérez J, Puig N, Paiva B, et al. Utility of CD54, CD229, and CD319 for the identification of plasma cells in patients with clonal plasma cell diseases. Cytometry B Clin Cytom. 2016;90:91-100 pubmed 出版商
  126. Yawata N, Selva K, Liu Y, Tan K, Lee A, Siak J, et al. Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection. Mucosal Immunol. 2016;9:159-70 pubmed 出版商
  127. Kaushansky N, Eisenstein M, Boura Halfon S, Hansen B, Nielsen C, Milo R, et al. Role of a Novel Human Leukocyte Antigen-DQA1*01:02;DRB1*15:01 Mixed Isotype Heterodimer in the Pathogenesis of "Humanized" Multiple Sclerosis-like Disease. J Biol Chem. 2015;290:15260-78 pubmed 出版商
  128. Thomas K, Valenzuela N, Gjertson D, Mulder A, Fishbein M, Parry G, et al. An Anti-C1s Monoclonal, TNT003, Inhibits Complement Activation Induced by Antibodies Against HLA. Am J Transplant. 2015;15:2037-49 pubmed 出版商
  129. Weinberg A, Muresan P, Richardson K, Fenton T, Domínguez T, Bloom A, et al. Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccine. PLoS ONE. 2015;10:e0122431 pubmed 出版商
  130. Hong M, Sandalova E, Low D, Gehring A, Fieni S, Amadei B, et al. Trained immunity in newborn infants of HBV-infected mothers. Nat Commun. 2015;6:6588 pubmed 出版商
  131. Dudek Perić A, Ferreira G, Muchowicz A, Wouters J, Prada N, Martin S, et al. Antitumor immunity triggered by melphalan is potentiated by melanoma cell surface-associated calreticulin. Cancer Res. 2015;75:1603-14 pubmed 出版商
  132. Herbst S, Shah A, Mazon Moya M, Marzola V, Jensen B, Reed A, et al. Phagocytosis-dependent activation of a TLR9-BTK-calcineurin-NFAT pathway co-ordinates innate immunity to Aspergillus fumigatus. EMBO Mol Med. 2015;7:240-58 pubmed 出版商
  133. Tomimaru Y, Mishra S, Safran H, Charpentier K, Martin W, De Groot A, et al. Aspartate-β-hydroxylase induces epitope-specific T cell responses in hepatocellular carcinoma. Vaccine. 2015;33:1256-66 pubmed 出版商
  134. Fytianos K, Rodríguez Lorenzo L, Clift M, Blank F, Vanhecke D, von Garnier C, et al. Uptake efficiency of surface modified gold nanoparticles does not correlate with functional changes and cytokine secretion in human dendritic cells in vitro. Nanomedicine. 2015;11:633-44 pubmed 出版商
  135. Martin S, Dudek Perić A, Maes H, Garg A, Gabrysiak M, Demirsoy S, et al. Concurrent MEK and autophagy inhibition is required to restore cell death associated danger-signalling in Vemurafenib-resistant melanoma cells. Biochem Pharmacol. 2015;93:290-304 pubmed 出版商
  136. Vadasz S, JENSEN T, Moncada C, Girard E, Zhang F, Blanchette A, et al. Second and third trimester amniotic fluid mesenchymal stem cells can repopulate a de-cellularized lung scaffold and express lung markers. J Pediatr Surg. 2014;49:1554-63 pubmed 出版商
  137. Van Eyck L, Hershfield M, Pombal D, Kelly S, Ganson N, Moens L, et al. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency. J Allergy Clin Immunol. 2015;135:283-7.e5 pubmed 出版商
  138. Rueda C, Wells C, Gisslen T, Jobe A, Kallapur S, Chougnet C. Effect of chorioamnionitis on regulatory T cells in moderate/late preterm neonates. Hum Immunol. 2015;76:65-73 pubmed 出版商
  139. Hautefort A, Girerd B, Montani D, Cohen Kaminsky S, Price L, Lambrecht B, et al. T-helper 17 cell polarization in pulmonary arterial hypertension. Chest. 2015;147:1610-1620 pubmed 出版商
  140. Weed D, Vella J, Reis I, De La Fuente A, Gomez C, Sargi Z, et al. Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma. Clin Cancer Res. 2015;21:39-48 pubmed 出版商
  141. Rogacev K, Zawada A, Hundsdorfer J, Achenbach M, Held G, Fliser D, et al. Immunosuppression and monocyte subsets. Nephrol Dial Transplant. 2015;30:143-53 pubmed 出版商
  142. Ziblat A, Domaica C, Spallanzani R, Iraolagoitia X, Rossi L, Avila D, et al. IL-27 stimulates human NK-cell effector functions and primes NK cells for IL-18 responsiveness. Eur J Immunol. 2015;45:192-202 pubmed 出版商
  143. Yu C, Becker C, Metang P, Marches F, Wang Y, Toshiyuki H, et al. Human CD141+ dendritic cells induce CD4+ T cells to produce type 2 cytokines. J Immunol. 2014;193:4335-43 pubmed 出版商
  144. Li Z, Li W, Li N, Jiao Y, Chen D, Cui L, et al. γδ T cells are involved in acute HIV infection and associated with AIDS progression. PLoS ONE. 2014;9:e106064 pubmed 出版商
  145. Chao Y, Kaliaperumal N, Chretien A, Tang S, Lee B, Poidinger M, et al. Human plasmacytoid dendritic cells regulate IFN-α production through activation-induced splicing of IL-18Rα. J Leukoc Biol. 2014;96:1037-46 pubmed 出版商
  146. Li G, Cheng M, Nunoya J, Cheng L, Guo H, Yu H, et al. Plasmacytoid dendritic cells suppress HIV-1 replication but contribute to HIV-1 induced immunopathogenesis in humanized mice. PLoS Pathog. 2014;10:e1004291 pubmed 出版商
  147. Ramirez A, van der Flier W, Herold C, Ramonet D, Heilmann S, Lewczuk P, et al. SUCLG2 identified as both a determinator of CSF A?1-42 levels and an attenuator of cognitive decline in Alzheimer's disease. Hum Mol Genet. 2014;23:6644-58 pubmed 出版商
  148. Longman R, Diehl G, Victorio D, Huh J, Galan C, Miraldi E, et al. CX?CR1? mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. J Exp Med. 2014;211:1571-83 pubmed 出版商
  149. Balan S, Ollion V, Colletti N, Chelbi R, Montanana Sanchis F, Liu H, et al. Human XCR1+ dendritic cells derived in vitro from CD34+ progenitors closely resemble blood dendritic cells, including their adjuvant responsiveness, contrary to monocyte-derived dendritic cells. J Immunol. 2014;193:1622-35 pubmed 出版商
  150. Jitschin R, Braun M, Büttner M, Dettmer Wilde K, Bricks J, Berger J, et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood. 2014;124:750-60 pubmed 出版商
  151. Wilson E, Singh A, Hullsiek K, Gibson D, Henry W, Lichtenstein K, et al. Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection. J Infect Dis. 2014;210:1396-406 pubmed 出版商
  152. Klinker M, Lizzio V, Reed T, Fox D, Lundy S. Human B Cell-Derived Lymphoblastoid Cell Lines Constitutively Produce Fas Ligand and Secrete MHCII(+)FasL(+) Killer Exosomes. Front Immunol. 2014;5:144 pubmed 出版商
  153. Fredriksson K, Mishra A, Lam J, Mushaben E, Cuento R, Meyer K, et al. The very low density lipoprotein receptor attenuates house dust mite-induced airway inflammation by suppressing dendritic cell-mediated adaptive immune responses. J Immunol. 2014;192:4497-509 pubmed 出版商
  154. Shey M, Nemes E, Whatney W, de Kock M, Africa H, Barnard C, et al. Maturation of innate responses to mycobacteria over the first nine months of life. J Immunol. 2014;192:4833-43 pubmed 出版商
  155. Saulep Easton D, Vincent F, Le Page M, Wei A, Ting S, Croce C, et al. Cytokine-driven loss of plasmacytoid dendritic cell function in chronic lymphocytic leukemia. Leukemia. 2014;28:2005-15 pubmed 出版商
  156. Sereti I, Estes J, Thompson W, Morcock D, Fischl M, Croughs T, et al. Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration. PLoS Pathog. 2014;10:e1003890 pubmed 出版商
  157. Narita T, Ishida T, Masaki A, Suzuki S, Ito A, Mori F, et al. HTLV-1 bZIP factor-specific CD4 T cell responses in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation. J Immunol. 2014;192:940-7 pubmed 出版商
  158. Wick D, Webb J, Nielsen J, Martin S, Kroeger D, Milne K, et al. Surveillance of the tumor mutanome by T cells during progression from primary to recurrent ovarian cancer. Clin Cancer Res. 2014;20:1125-34 pubmed 出版商
  159. Park S, Veerapu N, Shin E, Biancotto A, McCoy J, Capone S, et al. Subinfectious hepatitis C virus exposures suppress T cell responses against subsequent acute infection. Nat Med. 2013;19:1638-42 pubmed 出版商
  160. Krishnan S, Wilson E, Sheikh V, Rupert A, Mendoza D, Yang J, et al. Evidence for innate immune system activation in HIV type 1-infected elite controllers. J Infect Dis. 2014;209:931-9 pubmed 出版商
  161. Tan A, Hoang L, Chin D, Rasmussen E, Lopatin U, Hart S, et al. Reduction of HBV replication prolongs the early immunological response to IFN? therapy. J Hepatol. 2014;60:54-61 pubmed 出版商
  162. Avanzi S, Leoni V, Rotola A, Alviano F, Solimando L, Lanzoni G, et al. Susceptibility of human placenta derived mesenchymal stromal/stem cells to human herpesviruses infection. PLoS ONE. 2013;8:e71412 pubmed 出版商
  163. Nakayama K, Lee C, Batchelder C, Tarantal A. Tissue specificity of decellularized rhesus monkey kidney and lung scaffolds. PLoS ONE. 2013;8:e64134 pubmed 出版商
  164. Reuter M, Yuan S, Marx P, Kutzler M, Weiner D, Betts M. DNA-based HIV vaccines do not induce generalized activation in mucosal tissue T cells. Hum Vaccin Immunother. 2012;8:1648-53 pubmed 出版商
  165. Landsverk O, Ottesen A, Berg Larsen A, Appel S, Bakke O. Differential regulation of MHC II and invariant chain expression during maturation of monocyte-derived dendritic cells. J Leukoc Biol. 2012;91:729-37 pubmed 出版商
  166. Ruffell B, Au A, Rugo H, Esserman L, Hwang E, Coussens L. Leukocyte composition of human breast cancer. Proc Natl Acad Sci U S A. 2012;109:2796-801 pubmed 出版商
  167. Souza Lemos C, de Campos S, Teva A, Corte Real S, Fonseca E, Porrozzi R, et al. Dynamics of immune granuloma formation in a Leishmania braziliensis-induced self-limiting cutaneous infection in the primate Macaca mulatta. J Pathol. 2008;216:375-86 pubmed 出版商
  168. Vodyanik M, Slukvin I. Directed differentiation of human embryonic stem cells to dendritic cells. Methods Mol Biol. 2007;407:275-93 pubmed 出版商
  169. Yeaman G, Asin S, Weldon S, Demian D, Collins J, Gonzalez J, et al. Chemokine receptor expression in the human ectocervix: implications for infection by the human immunodeficiency virus-type I. Immunology. 2004;113:524-33 pubmed
  170. Boxall S, McCormick J, Beverley P, Strobel S, De Filippi P, Dawes R, et al. Abnormal cell surface antigen expression in individuals with variant CD45 splicing and histiocytosis. Pediatr Res. 2004;55:478-84 pubmed
  171. Braun R, Foerster M, Grahmann P, Haefner D, Workalemahu G, Kroegel C. Phenotypic and molecular characterization of CD103+ CD4+ T cells in bronchoalveolar lavage from patients with interstitial lung diseases. Cytometry B Clin Cytom. 2003;54:19-27 pubmed
  172. Hertel L, Lacaille V, Strobl H, Mellins E, Mocarski E. Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus. J Virol. 2003;77:7563-74 pubmed
  173. Higashi N, Morikawa A, Fujioka K, Fujita Y, Sano Y, Miyata Takeuchi M, et al. Human macrophage lectin specific for galactose/N-acetylgalactosamine is a marker for cells at an intermediate stage in their differentiation from monocytes into macrophages. Int Immunol. 2002;14:545-54 pubmed
  174. McIlroy D, Troadec C, Grassi F, Samri A, Barrou B, Autran B, et al. Investigation of human spleen dendritic cell phenotype and distribution reveals evidence of in vivo activation in a subset of organ donors. Blood. 2001;97:3470-7 pubmed
  175. Gopinath R, Hanna L, Kumaraswami V, Perumal V, Kavitha V, Vijayasekaran V, et al. Perturbations in eosinophil homeostasis following treatment of lymphatic filariasis. Infect Immun. 2000;68:93-9 pubmed
  176. Basch R, Zhang X, Dolzhanskiy A, Karpatkin S. Expression of CD41 and c-mpl does not indicate commitment to the megakaryocyte lineage during haemopoietic development. Br J Haematol. 1999;105:1044-54 pubmed
  177. Lee B, Sharron M, Montaner L, Weissman D, Doms R. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc Natl Acad Sci U S A. 1999;96:5215-20 pubmed
  178. Schiff D, Rae J, Martin T, Davis B, Curnutte J. Increased phagocyte Fc gammaRI expression and improved Fc gamma-receptor-mediated phagocytosis after in vivo recombinant human interferon-gamma treatment of normal human subjects. Blood. 1997;90:3187-94 pubmed
  179. Genc K, Dona D, Reder A. Increased CD80(+) B cells in active multiple sclerosis and reversal by interferon beta-1b therapy. J Clin Invest. 1997;99:2664-71 pubmed